JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
FRISCO, Texas—Darby Anderson, the Executive Vice President and Chief Legislative Officer of Addus HomeCare Corp (NASDAQ:ADUS), recently conducted a series of transactions involving the company’s stock. According to a recent SEC filing, Anderson sold 1,342 shares of Addus HomeCare on February 24 at an average price of $108.18 per share, totaling $145,177. This sale was made under a previously established 10b5-1 plan to cover tax obligations related to the vesting of restricted stock awards. The transaction comes as Addus HomeCare, currently valued at $1.74 billion, maintains strong financial health with an excellent liquidity position, as indicated by InvestingPro data showing a current ratio of 2.11.
Earlier, on February 21, Anderson acquired 5,150 shares of common stock at no cost, as part of a vesting schedule. These shares will fully vest in equal installments over the next three years, contingent on continued service and other customary conditions. Following these transactions, Anderson holds 44,562 shares of Addus HomeCare directly. According to InvestingPro analysis, the company demonstrates robust financial performance with a 10.15% revenue growth and strong cash flows. InvestingPro subscribers have access to 12 additional key insights about ADUS, along with comprehensive financial metrics and expert analysis in the Pro Research Report.
In other recent news, Addus HomeCare Corporation reported its fourth-quarter 2024 earnings, which exceeded analyst expectations. The company achieved an earnings per share (EPS) of $1.38, surpassing the forecast of $1.35, and reported revenue of $297.1 million, higher than the anticipated $284.28 million. Despite these positive financial results, the company’s stock experienced a decline, which may reflect investor concerns about external factors or internal challenges. Additionally, Addus HomeCare completed a significant acquisition and introduced new technology for caregivers, signaling continued strategic growth. The company faces ongoing challenges in the clinical labor market, particularly concerning nursing staff, and potential changes in Medicaid policy remain a concern. Addus HomeCare’s full-year revenue reached $1.2 billion, marking a 9.1% increase from the previous year, indicating robust growth. The company anticipates a 10% annual revenue growth and has set targets for growth in personal care hours and the hospice segment. Analyst feedback from firms like Bank of America and RBC Capital Markets has been part of the ongoing dialogue about the company’s strategic direction and market conditions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.